scispace - formally typeset
Search or ask a question

Can You give some information about hexahydrocannabinol? 


Best insight from top research papers

Hexahydrocannabinol (HHC) is a cannabinoid compound that has emerged as a "legal" replacement for THC and cannabis. It has been sold as a cheaper alternative to controlled Δ9-THC and is available in various branded and unbranded products, including "legal highs" . HHC is a semi-synthetic cannabinoid derived from hemp extracts, particularly cannabidiol (CBD), through chemical transformations . It has shown effects on the central nervous system, with lower potency than Δ9-THC, and an affinity for the CB1 receptor, suggesting possible therapeutic effects . However, its affinity for the CB1 receptor also indicates a potential for addiction and misuse . The harmful potential of HHC is not well-described due to the lack of effective analytical methods for its detection in biological matrices . HHC has been found in commercial hemp-derived products, but its prevalence and pharmacological properties are still limitedly understood . Additionally, preclinical studies have shown that HHC and its analogs have anti-angiogenic effects, inhibiting tumor growth by targeting VEGF-mediated angiogenesis signaling .

Answers from top 4 papers

More filters
Papers (4)Insight
Hexahydrocannabinols (HHCs) are poorly studied cannabinoids found in small concentrations in hemp plants.
Hexahydrocannabinol (HHC) is a hydrogenated derivative of tetrahydrocannabinol (THC) that has been sold as a legal replacement to THC and cannabis.
Hexahydrocannabinol (HHC) is a semi-synthetic derivative of cannabidiol (CBD) that is added to cannabis products to produce psychotropic effects similar to Δ9-tetrahydrocannabinol (Δ9-THC).

Related Questions

Cannabis use in the world5 answersCannabis is a widely-used substance globally, with prevalence varying across countries and demographics. The historical use of cannabis dates back to ancient civilizations and is intertwined with various religions. Currently, cannabis is the most used illicit drug worldwide, with changing legal statuses and increasing scientific research on its effects and therapeutic potential. The prevalence of cannabis use disorder among adult users has increased significantly since the early 1990s, ranging from 20-33% depending on usage frequency. Recent surveys show high rates of cannabis use in North America, particularly in the United States and Canada, where public perception of risk associated with cannabis is decreasing. The lack of data on harmful usage patterns necessitates surveys to assess cannabis use and related harms, with a focus on designing feasible studies for larger samples.
Cannabis Sativa (hemp plant)4 answersCannabis sativa, also known as hemp, is a versatile plant with industrial, medicinal, and recreational uses. It synthesizes phytocannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), which have high and low psychoactive properties respectively. Scientists and cultivators are working on developing improved production systems for high-cannabinoid hemp cultivars, considering factors such as flowering date, shoot-tip cannabinoid concentration, plant architecture, and inflorescence biomass. Genetic variation exists for photoperiod sensitivity in hemp, and the identification of specific loci associated with photoperiod-insensitive flowering can allow for the development of cultivars suitable for higher latitudes. Hemp root extracts have shown potential in ameliorating hyperglycemia and improving glucose homeostasis in diabetic mice, suggesting their anti-diabetic properties. Hemp has the potential to be a sustainable and ecologically benign crop, with the ability to absorb heavy metals, trap carbon, and suppress weeds.
Cannabinoids: Emerging sleep modulator5 answersCannabinoids have been found to play a role in the modulation of sleep, with evidence supporting their sleep-promoting effects. The endocannabinoid system, which includes cannabinoids like anandamide and 2-arachidonoylglycerol, interacts with neurotransmitter systems and can induce sleep. However, the therapeutic efficacy and safety of cannabinoid therapies for sleep disorders are still unclear, as there is insufficient evidence to support their routine clinical use. Despite this, there is promising preliminary evidence that suggests cannabinoids could be effective in treating sleep apnea, insomnia, nightmares, restless legs syndrome, rapid eye movement sleep behavior disorder, and narcolepsy. Further research is needed to investigate the safety and efficacy of cannabinoid therapies for sleep disorders using larger, controlled trials. While there is interest in using cannabinoids for sleep disorders, the evidence base is still limited, and practical considerations such as dosing, side effects, and drug interactions need to be taken into account.
What are the most important things about endocannabinoids?4 answersThe endocannabinoid system is a crucial physiologic system involved in maintaining human health. It oversees relaxation, appetite, sleep, protection, and memory processes. Recent research suggests that the effects of phytocannabinoids are not limited to cannabinoid receptors, but also involve interactions with non-cannabinoid receptors, producing pharmacological effects in diseases such as Alzheimer's, epilepsy, depression, neuropathic pain, cancer, and diabetes. Endocannabinoids and their receptors are found throughout the body, connecting brain activity with physical health and disease states. Endocannabinoids, such as anandamide and 2-arachidonoylglycerol, function as signaling molecules in mammals, stimulating feeding behavior and metabolic regulation. The endocannabinoid system consists of cannabinoid receptors and endogenous transmitters, which work through retrograde neurotransmission to modulate the release of neurotransmitters. Overall, the endocannabinoid system plays a crucial role in maintaining homeostasis and has potential implications for various disease states and therapeutic interventions.
How does cannabis sativa affect the human body?5 answersCannabis sativa affects the human body in various ways. It has been found to have antioxidant and anti-inflammatory properties, which can help in managing hypercholesterolemia and associated metabolic disorders such as obesity, diabetes, hypertension, and cardiovascular diseases. Cannabis extracts have also shown effectiveness against various bacteria and yeast, and have potential benefits for skin hydration, elasticity, and sebum production. Additionally, cannabis products have been found to affect different systems in the body such as the cardiovascular, respiratory, nervous, and immune systems, and have shown analgesic, antiemetic, anxiolytic, antidepressant, antimicrobial, antihypertensive, antitussive, and cardioprotective effects. However, it is important to note that cannabis can have both beneficial and harmful effects, and its abuse can negatively impact various organs and organ systems, as well as male and female potency. Further research is needed to fully understand the effects of cannabis on the human body and to determine safe and appropriate use.
Cannabis therapieformen inhaltsstoffe5 answersCannabis sativa contains various therapeutic compounds, including Longifolen, Humulenepoxid-I and -II, Caryophyllenol-I, and m-Mentha-1.8(9)-dien-5-ol. These substances are found in the essential oil of cannabis sativa and have been separated and identified. Additionally, cannabis sativa also contains nor-sesquiterpenoids, aliphatic compounds, and sterols. The therapeutic forms of cannabis include the use of its essential oil, which contains these beneficial compounds.

See what other people are reading

What is the potential impact of THC on sertraline's efficacy in treating ADHD?
4 answers
The potential impact of THC on sertraline's efficacy in treating ADHD involves complex interactions. THC, found in marijuana, can affect the metabolism of sertraline, an SSRI commonly used in ADHD treatment, leading to increased sertraline concentrations in adolescents. This interaction may heighten the risk of adverse effects like cough, diarrhea, dizziness, and fatigue when THC and sertraline are used together. Additionally, THC and CBD, another cannabinoid, inhibit cytochrome activity, alter serotonergic transmission, and modulate SSRI response, potentially influencing the overall effectiveness of sertraline in managing ADHD symptoms. Clinicians should be cautious when considering the concomitant use of THC and sertraline in youth prescribed SSRIs, as this interaction could impact treatment outcomes and tolerability.
What is known about cannabinoids acting on immune cells in the context of migraine?
5 answers
Cannabinoids, including phytocannabinoids like CBD, have been studied for their potential in migraine treatment. The endocannabinoid system (ECS) plays a crucial role in pain modulation, suggesting its involvement in migraine pathogenesis. Experimental evidence indicates that cannabinoids can modulate trigeminal excitability and nociceptive transmission, potentially offering relief from migraine-related pain. CBD, a prominent phytocannabinoid, has shown analgesic effects in migraine animal models by reducing trigeminal hyperalgesia and cytokine levels. While the exact mechanisms are not fully understood, targeting the ECS with cannabinoids presents a promising therapeutic approach for managing migraine attacks. However, further research, especially randomized human trials, is needed to determine the optimal doses, safety, and efficacy of cannabinoids in clinical migraine treatment.
How do cannabinoids act on macrophages and monocytes?
5 answers
Cannabinoids, such as THC, CBD, and synthetic agonists like WIN55,212-2, exert immunomodulatory effects on macrophages and monocytes. These compounds have been shown to inhibit pro-inflammatory responses by reducing cytokine production, inflammasome activation, and pyroptotic cell death in macrophages. Additionally, cannabinoids can generate tolerogenic dendritic cells and prime regulatory T cells, contributing to anti-inflammatory responses. Furthermore, cannabinoids like CBD and THC have been found to decrease the levels of pro-inflammatory cytokines by modulating key inflammatory signaling pathways, such as NLRP3 inflammasome and STAT3 pathways, in macrophages. Overall, cannabinoids demonstrate promising potential in regulating immune responses in macrophages and monocytes, suggesting a role in the development of novel therapeutic strategies for inflammatory disorders.
What is the problem and objectives of: Antiviral Potential of Cannabis-derived Compounds?
5 answers
The problem addressed in the research on the antiviral potential of cannabis-derived compounds lies in the urgent need for appropriately designed clinical trials to establish the safety and efficacy of these compounds. The objectives include exploring the antiviral activities of cannabinoids like cannabidiol (CBD) and delta-9-tetrahydrocannabinol (Δ9-THC) against viruses such as SARS-CoV-2, HIV, and herpes viruses, through mechanisms like inhibition of viral cell entry and proteases, as well as stimulation of innate immune responses. Additionally, the research aims to investigate the anti-inflammatory properties of cannabinoids for mitigating the cytokine storm in COVID-19 and controlling chronic inflammation in individuals with HIV.
What methods were previously used to investigate the Antiviral Potential of Cannabis-derived Compounds?
4 answers
Previous research has utilized various methods to explore the antiviral potential of cannabis-derived compounds. Studies have employed in silico, in vitro, and in vivo approaches to investigate the efficacy of cannabinoids like cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), and cannabigerolic acid (CBGA) against viruses such as SARS-CoV-2, HIV, and herpes viruses. These investigations have revealed mechanisms of action including inhibition of viral cell entry, viral protease inhibition, and stimulation of innate immune responses. Additionally, the anti-inflammatory properties of cannabinoids have been studied for their potential in mitigating the cytokine storm associated with COVID-19 and managing chronic inflammation in individuals with HIV. The use of computational modeling has also been employed to assess the interactions of cannabis phytoligands with viral spike-ACE2 complexes and main proteases, indicating their potential as dual inhibitors of viral entry and replication machinery.
How does insomnia impact the cognitive abilities and academic performance of primary school students?
5 answers
Insomnia significantly impacts the cognitive abilities and academic performance of primary school students. Research indicates that children with sleep disorders experience higher memory problems, slower math problem-solving, attention difficulties, and lower grades in subjects like mathematics, language, and physical education. Additionally, insufficient sleep duration is associated with older age, having electronic devices in the bedroom, late bedtime, and less engagement in physical and sports activities, leading to shorter sleep duration and sleep deficits. Furthermore, excessive daytime sleepiness is linked to verbal and complex cognitive functions, affecting reading comprehension, spelling, and math skills. Studies also show that insomnia severity can be reduced with CBD supplementation, potentially improving sleep quality and cognitive performance in primary insomnia cases. Overall, addressing sleep disorders and promoting healthy sleep habits in educational settings can enhance academic outcomes and cognitive functions in primary school students.
Cannabis and acute psychosis
5 answers
Cannabis has been associated with acute psychosis, showing three distinct relationships: acute psychosis during intoxication, lasting beyond intoxication, and persistent psychosis not time-locked to exposure. Experimental studies demonstrate that cannabis and its components induce transient positive, negative, and cognitive symptoms in healthy individuals. Highly psychosis-prone individuals experience enhanced psychotic states under acute cannabis influence, indicating vulnerability to its effects. Cannabis-induced psychosis (CP) and acute schizophrenia (AS) exhibit differences in demographic, premorbid, and clinical features, suggesting distinct clinical entities. While the association between cannabinoids and psychosis meets several criteria for causality, including dose-response and biological plausibility, it is not sufficient alone to cause persistent psychotic disorders. Further research is needed to understand the neural mechanisms underlying this link and identify factors contributing to cannabinoid-related psychosis risk.
What will be the statement of purpose about using vape of grade 11 student?
5 answers
The statement of purpose regarding the use of vape by a grade 11 student would involve understanding the factors influencing vaping behavior. Research indicates that peer influence plays a significant role in initiating and sustaining adolescent vaping habits. Additionally, the availability of vaping devices among friends and the appeal of new flavors contribute to the initiation of vaping among adolescents. Factors such as anxiety/stress, socializing activities, and routine daily habits like gaming or studying are also linked to adolescent vaping behaviors. Moreover, the desire to quit vaping is present among adolescents, driven by concerns about health effects, nicotine dependence, and the cost associated with vaping. Understanding these influences and motivations is crucial for designing effective interventions to address adolescent vaping habits and support cessation efforts.
Cannabis in the elderly
5 answers
Cannabis use among the elderly is increasing, driven by both medical potential and recreational purposes. However, research on the effects of cannabinoids in aging individuals is limited, despite age-related changes in cannabinoid receptors and potential interactions with comorbidities and medications. Concerns exist regarding drug interactions with medical marijuana, especially in older adults with existing conditions like cardiovascular disease and neuropsychiatric disorders. A pilot study highlighted older adults' positive attitudes towards cannabis as a medicinal product but also revealed gaps in knowledge and reliance on internet sources for information. The scoping review emphasized inconsistent therapeutic effects of medical cannabis in older adults, with associations to mental health issues, substance use, and acute healthcare utilization. Further research is needed to understand the implications and risks of cannabis use in the elderly population.
Which ICH guideline for cannabis oil?
4 answers
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has published guidelines related to cannabis use. The ICH S5(R2) guideline focuses on preclinical safety studies for new medicinal products, emphasizing toxicity to the reproductive system and embryo development. Additionally, the ICH E6(R2) Good Clinical Practice (GCP) guideline provides standards for designing, conducting, and reporting clinical trials, with ongoing revisions to adapt to the current regulatory environment. Furthermore, a clinical practice guideline was developed for medical cannabinoid use in primary care, emphasizing evidence-based decision-making and shared decision-making processes. Therefore, the ICH guidelines relevant to cannabis use encompass preclinical safety assessments, clinical trial conduct standards, and medical cannabinoid prescribing recommendations for primary care settings.
What is the impact of psychological treatment on functioning for those with first episode psychosis?
5 answers
Psychological treatments have shown varying impacts on functioning for individuals with first episode psychosis (FEP). Cognitive behavioral therapy (CBT) and third wave cognitive-behavioral therapies have demonstrated effectiveness in improving functioning in patients with schizophrenia. Initiating treatment within 14 days of FEP diagnosis has been linked to a lower likelihood of self-harm. Specific cognitive behavioral therapy for cannabis cessation has shown positive outcomes in reducing cannabis use severity and improving functioning in FEP cannabis users. Psychological treatment has been found to be equally effective in improving functioning in ultra-high-risk individuals as in the general adolescent help-seeking population, with a reduction in attenuated psychotic symptoms over time. Overall, psychosocial interventions during the critical period after FEP onset can significantly influence prognosis and functioning.